Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis - United States, 2025 [0.03%]
2025年美国关于恩可卡培作为HIV暴露前预防用药的临床推荐意见
Rupa R Patel,Karen W Hoover,Allison Lale et al.
Rupa R Patel et al.
In 2023, approximately 39,000 persons received a diagnosis of HIV in the United States. Although HIV preexposure prophylaxis (PrEP) is highly effective in preventing HIV infection, acceptance of, adherence to, and persistence taking the ava...
Notes from the Field: Differences in Suicide Rates, by Race and Ethnicity and Age Group - United States, 2018-2023 [0.03%]
美国2018-2023年不同种族和年龄段自杀率差异——地方病防制报告笔记
Deborah M Stone,Alison L Cammack,Eric G Carbone
Deborah M Stone
Notes from the Field: Invasive Group G β-Hemolytic Streptococcus Outbreak at a Long-Term Care Facility - Pennsylvania, 2024 [0.03%]
现场报告：2024年美国宾夕法尼亚州一家长期护理机构的侵袭性群组Gβ溶血性链球菌暴发事件注释
Monica Giacomucci,Laxmi Modali,Cara Bicking Kinsey et al.
Monica Giacomucci et al.
Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season [0.03%]
2024-2025年流感季节美国流感住院监测网络流感相关住院情况（高严重度季节）
Alissa O&#x;Halloran,Jennifer Whitmill Habeck,Matthew Gilmer et al.
Alissa O&#x;Halloran et al.
The U.S. 2024-25 influenza season was a high-severity season characterized by co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. Data from the Influenza Hospitalization Surveillance Network covering 9% of the U.S. population, wer...
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025 [0.03%]
一名无已知暴露史的儿童感染高致病性甲型禽流感（H5N1）病毒——2024年12月至2025年1月旧金山，加利福尼亚州
Farrell A Tobolowsky,Eric Morris,Lina Castro et al.
Farrell A Tobolowsky et al.
In response to a highly pathogenic avian influenza (HPAI) A(H5N1) outbreak in U.S. dairy cows detected in March 2024, with subsequent identification of human cases, the San Francisco Department of Public Health instituted enhanced influenza...
Outbreak of Neisseria meningitidis Conjunctivitis in Military Trainees - Texas, February-May 2025 [0.03%]
2025年2—5月美国德克萨斯州新兵训练营脑膜炎奈瑟菌结膜炎暴发
Susan J Ching,Ga On Jung,Angela Osuna et al.
Susan J Ching et al.
Viral and allergic conjunctivitis are more common than bacterial conjunctivitis in healthy immunocompetent adults. Neisseria meningitidis is an uncommon cause of bacterial conjunctivitis. During February-May 2025, an outbreak of 41 meningoc...
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025 [0.03%]
关于使用clesrovimab预防婴幼儿严重呼吸道合胞病毒相关下呼吸道感染的建议——美国免疫实践咨询委员会 recommendations of the advisory committee on immunization practices (acip) - united states, 2025
Danielle L Moulia,Ruth Link-Gelles,Helen Y Chu et al.
Danielle L Moulia et al.
Before the introduction of universal respiratory syncytial virus (RSV) immunization recommendations for infants, RSV was the leading cause of hospitalization among infants in the United States. Since 2023, CDC's Advisory Committee on Immuni...
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season [0.03%]
2025-26年流行季流感疫苗预防和控制指南：免疫实践咨询委员会的建议
Lisa A Grohskopf,Lenee H Blanton,Jill M Ferdinands et al.
Lisa A Grohskopf et al.
This report updates the 2024-25 recommendations of the Advisory Committee on Immunization Practices (ACIP) concerning the use of seasonal influenza vaccines in the United States. Routine annual influenza vaccination is recommended for all p...
Drug Overdose Deaths Involving Stimulants - United States, January 2018-June 2024 [0.03%]
2018年1月—2024年6月美国兴奋剂过量死亡情况
Lauren J Tanz,Kimberly D Miller,Amanda T Dinwiddie et al.
Lauren J Tanz et al.
Drug overdose deaths involving stimulants have increased in the United States since 2011. This report describes characteristics of stimulant-involved overdose deaths during January 2021-June 2024 using CDC's State Unintentional Drug Overdos...
Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 [0.03%]
2023年10月-2024年3月美国婴儿呼吸道合胞病毒免疫接种覆盖率通过单克隆抗体尼塞维玛b或母体疫苗接种情况进行评估
Ellen O Boundy,Hannah Fast,Tara C Jatlaoui et al.
Ellen O Boundy et al.
Respiratory syncytial virus (RSV) is the leading cause of infant hospitalization in the United States. A new RSV monoclonal antibody (nirsevimab) for infants and an RSV vaccine for pregnant women were recommended by the Advisory Committee o...